EUVIMEDEUVIMED entdecken
Crossref

HSP90AA1 inhibits autophagy to promote tumor growth: A novel therapeutic target in endometrial cancer

Lujiadai Xue, Pengfei Wang, Chenlingzi Huang, Yuanhong Chen, Qinghua Lin, Nan Li, Shuai Wang, Hu Li, Xian Zhang

Cellular Signalling · 2027-01 · 149 · 112902

DOI: 10.1016/j.cellsig.2026.112902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Lujiadai Xue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: HSP90AA1 functions as a molecular chaperone involved in stabilizing multiple oncogenic clients. Its role in endometrial cancer (EC), particularly regarding autophagy regulation, remains unclear. METHODS: HSP90AA1 expression was examined using UALCAN and Human Protein Atlas (HPA) databases, followed by immunohistochemical (IHC) validation in 80 EC tissues and 20 normal controls. Stable knockout and transient overexpression of HSP90AA1 were established in Ishikawa and HEC-1A cells. Colony formation, flow cytometry, and subcutaneous xenograft models were used to evaluate proliferation and tumor growth. Autophagic flux was assessed by detecting Beclin-1, the LC3B-II/I ratio, and p62, and was further confirmed by transmission electron microscopy (TEM) and mCherry-GFP-LC3B tandem fluorescent reporter assays. Mechanistically, the involvement of the AKT pathway was validated using the AKT activator SC79, and the functional dependence on autophagy was confirmed via chloroquine (CQ) rescue experiments. In vivo combination therapy with 17-AAG (17-allylamino-17-demethoxygeldanamycin, an HSP90 inhibitor) and rapamycin (an mTOR inhibitor and autophagy activator) was conducted in xenograft-bearing mice, with systemic safety evaluated by body weight and H&E staining of major organs. RESULTS: HSP90AA1 was significantly overexpressed in tumor tissues, and its high expression correlated with advanced International Federation of Gynecology and Obstetrics stage, lymphovascular space invasion (LVSI), lymph node metastasis, and higher tumor grade. sgHSP90AA1 suppressed colony formation and reduced xenograft tumor volume and weight, while overexpression decreased apoptosis. Mechanistic analysis showed that sgHSP90AA1 increased Beclin-1 expression, elevated the LC3B-II/I ratio, and reduced p62 levels, whereas overexpression produced opposite effects. TEM and confocal imaging revealed abundant autolysosomes and enhanced autophagic flux in knockout cells. SC79 reversed the effects of HSP90AA1 knockout, and CQ reversed its anti-proliferative effect, indicating that HSP90AA1 acts upstream of AKT to suppress autophagy. The combination of 17-AAG and rapamycin synergistically suppressed tumor growth, accompanied by decreased Ki67 and p62 expression and increased LC3B expression, without observable organ toxicity or body weight loss. CONCLUSIONS: HSP90AA1 drives tumor growth in endometrial cancer by suppressing autophagy via the AKT pathway. Concurrent inhibition of HSP90AA1 and activation of autophagy may offer an effective therapeutic approach.

Schlagwörter

Stichwörter der Autor:innen

17-AAGAutophagyEndometrial cancerHSP90AA1Rapamycin

Autor:innen und Institutionen

  • Department of Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
  • Department of Gynecology, Dongguan Eastern Central Hospital, Dongguan 523000, China.
  • Department of Gynecology, The Affiliated Shunde Hospital of Jinan University, Foshan 528000, China.
  • Department of Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China. Electronic address: Linan@jnu.edu.cn.
  • Department of Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China; Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Guangzhou 510630, China. Electro…
  • Department of Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China. Electronic address: lihu1981@jnu.edu.cn.

Förderung

  • Guangzhou Municipal Science and Technology Program key projects

Zitieren

APA

Xue, L., Wang, P., Huang, C., Chen, Y., Lin, Q., Li, N., Wang, S., Li, H., & Zhang, X. (2027). HSP90AA1 inhibits autophagy to promote tumor growth: A novel therapeutic target in endometrial cancer. Cellular Signalling, 149, 112902. https://doi.org/10.1016/j.cellsig.2026.112902

Vancouver

Xue L, Wang P, Huang C, Chen Y, Lin Q, Li N, et al. HSP90AA1 inhibits autophagy to promote tumor growth: A novel therapeutic target in endometrial cancer. Cellular Signalling. 2027;149:112902. doi:10.1016/j.cellsig.2026.112902

BibTeX
@article{Xue2027,
  author = {Xue, Lujiadai and Wang, Pengfei and Huang, Chenlingzi and Chen, Yuanhong and Lin, Qinghua and Li, Nan and Wang, Shuai and Li, Hu and Zhang, Xian},
  title = {HSP90AA1 inhibits autophagy to promote tumor growth: A novel therapeutic target in endometrial cancer},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {149},
  pages = {112902},
  doi = {10.1016/j.cellsig.2026.112902}
}
Kostenlos starten →